Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Consumer World Report.
Press releases published on May 23, 2025

iHerb Memperkenalkan California Gold Nutrition® BEAUTY
IRVINE, California, May 23, 2025 (GLOBE NEWSWIRE) -- iHerb, sebuah syarikat yang menjadi destinasi global terkemuka dalam bidang kesihatan dan kesejahteraan, dengan bangganya mengumumkan pelancaran California Gold Nutrition® BEAUTY. Ia merupakan rangkaian …

iHerb Lança California Gold Nutrition® BEAUTY
IRVINE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- A iHerb, um destino global líder em saúde e bem-estar, anuncia com orgulho o lançamento da California Gold Nutrition® BEAUTY, uma nova linha holística de autocuidado criada com ingredientes premium que …

iHerb เปิดตัว California Gold Nutrition® BEAUTY
เออร์ไวน์ รัฐแคลิฟอร์เนีย, May 23, 2025 (GLOBE NEWSWIRE) -- iHerb ผู้นำระดับโลกด้านสุขภาพและความเป็นอยู่ที่ดี ภาคภูมิใจที่จะประกาศเปิดตัว California Gold Nutrition® BEAUTY …

iHerb 推出 California Gold Nutrition® BEAUTY 系列
加利福尼亚州尔湾, May 23, 2025 (GLOBE NEWSWIRE) -- 全球领先的健康与保健平台 iHerb 隆重推出 California Gold Nutrition® BEAUTY,这是全新且全方位的个人护理系列,甄选高端成分,致力于实现由内而外的健康美。 该品牌首发产品包括专为强韧健康秀发研发的头发多维生素及高效纯净基础护发品。 作为 iHerb 规模最大、最受信赖的自有品牌,California Gold Nutrition …

iHerb California Gold Nutrition® BEAUTY 系列隆重登場
加州爾灣, May 23, 2025 (GLOBE NEWSWIRE) -- 全球頂尖的健康及保健網站 iHerb 欣然宣佈推出嶄新的全方位自我護理系列 California Gold Nutrition® BEAUTY,採用優質成分製造,助您促進由內而外的健康。 該品牌首次推出一系列針對頭髮的綜合維他命,以及潔淨高效的護髮必需品,打造強韌又健康的秀髮。 作為 iHerb 最具規模及信譽的自家品牌,California Gold Nutrition …

Self-driving Cars Market worth 76,217 thousand units in 2032, Globally, at a CAGR of 6.8%, says MarketsandMarkets™
Delray Beach, FL, May 22, 2025 (GLOBE NEWSWIRE) -- Self-Driving Cars Market is projected to reach from 37,090 thousand units in 2024 to 76,217 thousand units in 2035, at a CAGR of 6.8%, as per the recent study by MarketsandMarkets™. The self-driving cars …

El servicio nacional Drones como un Servicio (DaaS) de ZenaTech crece con el cierre de su quinta adquisición, sumando capacidades de inspección de líneas eléctricas
VANCOUVER, Columbia Británica, May 22, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), soluciones …

Brompton Split Banc Corp. Renews At-the-Market Equity Program
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- (TSX: SBC, SBC.PR.A) Brompton Split Banc Corp. (the “Fund”) is pleased to announce it has renewed its at-the-market equity …

INTELLIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

ADTRAN ALERT: Bragar Eagel & Squire, P.C. is Investigating ADTRAN Holdings, Inc. on Behalf of ADTRAN Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

SEMLER ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

APPLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Apple Inc. on Behalf of Apple Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of …

Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce …

CECOCECO to Unveil ArtMorph Innovation at AIA Conference on Architecture & Design 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- CECOCECO, a leading innovator in the lighting and display industry, is excited to announce its participation in the AIA Conference on Architecture …

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025
ROCKVILLE, Md. and SUZHOU, China, May 22, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced that new clinical data from two …

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm– UNH
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and May 12, 2025, both dates inclusive (the “Class …

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …